Genetic vaccine for metastatic breast cancer shows promise in mice studies
Scientists at the University of Nebraska Medical Center have developed a genetic vaccine for metastatic breast cancer and other tumors, which shows great promise in early studies in mice. The vaccine uses a combination of components that are being used in existing clinical trials for other diseases. The vaccine combines DNA and adenovirus gene delivery mechanisms. Together, the combination can deliver the p53 gene as a vaccine for breast cancer.
University of Nebraska Medical Center
Message posted by: Wouter Kalle